| 1 | [SID51085108] | Active | AC50 | 4.398 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | AC50 | 4.398 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID51085108] | Active | AbsAC1000_uM | 6.046 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | AbsAC1000_uM | 6.046 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 3 | [SID51085108] | Active | AbsAC35_uM | 6.94 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity [AID652041, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | AbsAC35_uM | 6.94 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity | | AID | 652041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID51085108] | Active | AC50 | 6.975 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | AC50 | 6.975 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID51085108] | Active | AbsAC35_uM | 12.22 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity [AID652047, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | AbsAC35_uM | 12.22 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID51085108] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID51085108] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID51085108] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID51085108] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID51085108] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID51085108] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID51085108] | Active | Potency | 39.8107 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 13 | [SID51085108] | Active | Potency | 39.8107 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 14 | [SID51085108] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID51085108] | Active | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID51085108] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID51085108] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID51085108] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 19 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 20 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 21 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 22 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 23 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 24 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 25 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 26 | [SID51085108] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 27 | [SID51085108] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 28 | [SID51085108] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID651616, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 651616 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 29 | [SID51085108] | Active | | | MLPCN Streptokinase Expression Inhibition [AID1662, Type: screening] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | MLPCN Streptokinase Expression Inhibition | | AID | 1662 | | BioAssay type | screening | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 30 | [SID51085108] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 31 | [SID51085108] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 32 | [SID51085108] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 33 | [SID51085108] | Inactive | Potency | 0.2818 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 0.2818 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 34 | [SID51085108] | Inactive | Potency | 0.2818 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 0.2818 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 35 | [SID51085108] | Inactive | Potency | 17.7828 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID51085108] | Inactive | Potency | 19.9526 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 37 | [SID51085108] | Inactive | Potency | 19.9526 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 38 | [SID51085108] | Inactive | Potency | 19.9526 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 39 | [SID51085108] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 40 | [SID51085108] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 41 | [SID51085108] | Inactive | Potency | 28.1838 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 42 | [SID51085108] | Inactive | Potency | 28.1838 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 43 | [SID51085108] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 44 | [SID51085108] | Inactive | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity [AID2221, Type: screening] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity | | AID | 2221 | | BioAssay type | screening | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 45 | [SID51085108] | Inactive | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex [AID435030, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex | | AID | 435030 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 46 | [SID51085108] | Inactive | | | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID504621, Type: screening] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 504621 | | BioAssay type | screening | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 47 | [SID51085108] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN. [AID2066, Type: screening] | Agp1p [Saccharomyces cerevisiae S288c] [gi:85666113] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN. | | AID | 2066 | | BioAssay type | screening | | Target | Agp1p [Saccharomyces cerevisiae S288c] [gi:85666113] | | PubMed | | | Data Table |  |
|
| 48 | [SID51085108] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae specifically AGP1 Second Cherry Pick Compounds [AID2643, Type: screening] | Agp1p [Saccharomyces cerevisiae S288c] [gi:85666113] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae specifically AGP1 Second Cherry Pick Compounds | | AID | 2643 | | BioAssay type | screening | | Target | Agp1p [Saccharomyces cerevisiae S288c] [gi:85666113] | | PubMed | | | Data Table |  |
|
| 49 | [SID51085108] | Inactive | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 50 | [SID51085108] | Inactive | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51085108 | | CID | 24891764 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|